Dis-Chem lived up to demanding market expectations in its maiden year as a listed company, delivering a 30.8% rise in adjusted headline EPS (HEPS). But to justify its heady 36 p:e, the health and beauty retailer will have to keep on producing more of the same. Strongly in Dis-Chem’s favour is its highly resilient drugstore model, in which the front-store profit engine is supported by a back-of-store customer-drawing pharmacy. It is the same model followed by Dis-Chem’s larger arch-rival, Clicks, which is now trading on a 27.6 p:e. At the retail sales level Dis-Chem lags behind Clicks by a big margin. In its year to February, Dis-Chem reported retail sales of R15.6bn, a retail operating profit of R1.1bn and an operating margin of 7%. In its six months to February, Clicks’ retail sales stood at R9.24bn (annualised R18.5bn), retail operating profit at R700m (R1.4bn annualised) and operating margin at 7.6%. Clicks generates roughly the same level of retail sales and operating profit in ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00.